[Multiple sclerosis--biochemical-immunologic and therapeutic aspects]. 1990

Z Maciejek
Klinicznego OddziaƂu Neurologicznego Wojskowego Szpitala Klinicznego z Poliklinika, Bydgoszczy.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Z Maciejek
January 1975, Annals of clinical and laboratory science,
Z Maciejek
January 2011, The Mount Sinai journal of medicine, New York,
Z Maciejek
July 1970, Minnesota medicine,
Z Maciejek
August 1998, Physical medicine and rehabilitation clinics of North America,
Z Maciejek
September 1968, Acta neurologica et psychiatrica Belgica,
Z Maciejek
January 1982, Bulletin de la Societe belge d'ophtalmologie,
Z Maciejek
January 1983, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952),
Z Maciejek
May 2017, Neuroimaging clinics of North America,
Copied contents to your clipboard!